Skip to main content
SpringerLink
Log in

Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Increased oxidative stress (OS) in diabetes mellitus is one of the major factors leading to diabetic pathology. However, the mediators and mechanism that provoke OS in diabetes is not fully understood, and it is possible that accumulation of advanced glycation end products (AGEs) formed secondary to hyperglycemic conditions may incite circulating polymorphonuclear neutrophils (PMN) to generate reactive oxygen species (ROS). In this report, we aim to investigate the effect of AGE on reactive oxygen and nitrogen species generation and subsequent OS in PMN. AGE-HSA exert dose- and time-dependent enhancement of ROS and reactive nitrogen intermediates (RNI) generation by PMN. Increased ROS and RNI generation were found to be mediated through the upregulation of NADPH oxidase and inducible nitric oxide synthase (iNOS), respectively, as evident from the fact that AGE-treated neutrophils failed to generate ROS and RNI in presence of diphenyleneiodonium, a flavoprotein inhibitor for both enzymes. Further increased generation of ROS and RNI ceased when the cells were incubated with anti-RAGE antibody suggesting the involvement of AGE–RAGE interaction. Also increased malondialdehyde (MDA) and protein carbonyl formation in AGE-exposed PMN suggest induction of OS by AGE. This study provides evidence that AGEs may play a key role in the induction of oxidative stress through the augmentation of PMN-mediated ROS and RNI generation and this may be in part responsible for development of AGE-induced diabetic pathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820

    Article  PubMed  CAS  Google Scholar 

  2. Sharp PS, Rainbow S, Mukherjee S (2003) Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabet Med 20:575–579

    Article  PubMed  CAS  Google Scholar 

  3. John WG, Lamb EJ (1993) The Maillard or browning reaction in diabetes. Eye 7:230–237

    Article  PubMed  Google Scholar 

  4. Lapolla A, Piarulli F, Sartore G et al (2007) Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care 30:670–676

    Article  PubMed  CAS  Google Scholar 

  5. Piwowar A, Knapik-Krdecka M, Szczecinska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553

    Article  PubMed  CAS  Google Scholar 

  6. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 287:2570–2581

    Article  PubMed  CAS  Google Scholar 

  7. Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD (2011) Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes. Diabetes Care 34:442–447

    Article  PubMed  CAS  Google Scholar 

  8. Goh SY, Cooper ME (2008) The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93:1143–1152

    Article  PubMed  CAS  Google Scholar 

  9. Wada R, Yagihashi S (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann NY AcadSci 1043:598–604

    Article  CAS  Google Scholar 

  10. Al-Mesallamy HO, Hammad LN, El-Mamoun TA, Khalil BM (2011) Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy. J Diabetes Complicat 25(3):168–174

    Article  PubMed  Google Scholar 

  11. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB (2006) Diabetes and advanced glycation end products. Diabetes Care 29(6):1420–1429

    Article  PubMed  CAS  Google Scholar 

  12. Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. (Epub ahead of print)

  13. Pitocco D, Zaccardi F, Stasio ED, Romitelli F, Santini SA, Zuppi C, Ghirlanda G (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabetes Stud 7:15–25

    Article  Google Scholar 

  14. Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE (2005) Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 78:862–870

    Article  PubMed  CAS  Google Scholar 

  15. Hand WL, Hand DL, Vasquez Y (2007) Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Res Clin Pract 76:44–50

    Article  PubMed  CAS  Google Scholar 

  16. Gupta A, Tripathi AK, Tripathi RL, Madhu SV, Banerjee BD (2007) Advanced glycosylated end products mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys 44:373–378

    PubMed  CAS  Google Scholar 

  17. Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, Schmidt AM, Stern DM, Al-Mohanna FA, Kate S (2002) RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 71:433–444

    PubMed  CAS  Google Scholar 

  18. Takeuchi M, Yanase Y, Matsuura N, Yamagishi S, Kameda Y, Bucala R, Makita Z (2001) Immunological detection of a novel advanced glycation end products. Mol Med 7(11):783–791

    PubMed  CAS  Google Scholar 

  19. Habeeb AFSA (1996) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328

    Article  Google Scholar 

  20. Kalousová M, Krha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604

    PubMed  Google Scholar 

  21. Baron DN, Ahmed SA (1969) Intracellular concentrations of water and of the principal electrolytes determined by analysis of isolated human leucocytes. Clin Sci 37:205–219

    PubMed  CAS  Google Scholar 

  22. Pick E (1986) Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol 132:407–421

    Article  PubMed  CAS  Google Scholar 

  23. Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen, intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141:2407–2411

    PubMed  CAS  Google Scholar 

  24. Aydemir B, Onaran I, Kiziler AR, Alici B et al (2007) Increased oxidative damage of sperm and seminal plasma in men with idiopathic infertility is higher in patients with glutathione S-transferase Mu-1 null genotype. Asian J Androl 9:108–115

    Article  PubMed  CAS  Google Scholar 

  25. Girotti MJ, Khan N, Mclellan BA (1991) Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients. J Trauma-Inj Infect Crit Care 31(1):32–35

    Article  CAS  Google Scholar 

  26. Wong RKM, Pettit AI, Quinn PA, Jennings SC, Davies JE, Leong L Ng (2003) Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation 108:1858–1864

    Article  PubMed  CAS  Google Scholar 

  27. Ding Y, Kantarci A, Hasturk H, Trackman PC, Malabanan A, Van Dyke TE (2007) Activation of RAGE induces elevated O2− generation by mononuclear phagocytes in diabetes. J Leukoc Biol 81(2):520–527

    Article  PubMed  CAS  Google Scholar 

  28. Zhang FL, Gao HQ, Shen L (2007) Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. J Cardiovasc Pharmacol 50:434–440

    Article  PubMed  CAS  Google Scholar 

  29. Ayilavarapu S, Kantarci A, Fredman G, Turkoglu O, Omoril K, Liu H, Iwata T, Yagi M, Hasturk H, Van Dyke TE (2010) Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. J Immunol 184(3):1507–1515

    Article  PubMed  CAS  Google Scholar 

  30. Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM (2004) Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int 65:1664–1675

    Article  PubMed  CAS  Google Scholar 

  31. Rojas A, Caveda L, Romay C et al (1996) Effects of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages. Biochem Biophys Res Commun 225:358–362

    Article  PubMed  CAS  Google Scholar 

  32. Amore A, Cirina P, Mitola S et al (1997) Non-enzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 51:27–35

    Article  PubMed  CAS  Google Scholar 

  33. Lin CH, Lin YF, Chang MC et al (2001) Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: involvement of a p38 MAP kinase-dependent mechanism. Life Sci 69:2503–2515

    Article  PubMed  CAS  Google Scholar 

  34. Bechman JS, Beckman TV, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620–1624

    Article  Google Scholar 

  35. Pan HZ, Zhang H, Chang D et al (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551

    Article  PubMed  Google Scholar 

  36. Datta SK, Kumar V, Pathak R, Tripathi AK, Ahmed RS, Kalra OP, Banerjee BD (2010) Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and non-diabetic chronic kidney disease. Ren Fail 32(10):1189–1195

    Article  PubMed  CAS  Google Scholar 

  37. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF (1991) Inhibition of macrophage and endothelial nitric oxide synthase by DPI and its analogs. FASEB J 5:98–103

    PubMed  CAS  Google Scholar 

  38. O’Donnell BV, Tew DG, Jones OT, England PJ (1993) Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290:41–49

    PubMed  Google Scholar 

  39. Toure F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P, Rieu P (2008) Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J 416:255–261

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work is supported through a project funded by Indian Council of Medical research and one of the authors Savita Bansal is thankful to Council of Scientific and Industrial Research (CSIR), New Delhi, India for providing Junior Research Fellowship (NET). Authors are thankful to Prof. Rina Chakrabarti, Department of Zoology, University of Delhi and Dr. Sudip Dutta for providing necessary help in spectrofluorometric assays and manuscript editing, respectively.

Author information

Authors and Affiliations

  1. Biochemistry and Immunology Laboratory, Department of Biochemistry, University College of Medical Sciences (University of Delhi) and G.T.B. Hospital, Dilshad Garden, Delhi, 110095, India

    Savita Bansal, Manushi Siddarth, Diwesh Chawla, Basu D. Banerjee & Ashok K. Tripathi

  2. Department of Medicine, University College of Medical Sciences (University of Delhi) and G.T.B. Hospital, Dilshad Garden, Delhi, 110095, India

    S. V. Madhu

Authors
  1. Savita Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manushi Siddarth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diwesh Chawla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Basu D. Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. V. Madhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ashok K. Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok K. Tripathi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bansal, S., Siddarth, M., Chawla, D. et al. Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro. Mol Cell Biochem 361, 289–296 (2012). https://doi.org/10.1007/s11010-011-1114-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-1114-9

Keywords

Search

Navigation